As shown in Figure 2A, a study found that in bladder cancer, NNT-AS1 can up-regulate podocalyxin-like (PODXL) by sponging miR-1301-3p, which in turn activates the Wnt pathway-related proteins, including CDK1, cyclin D1, MYC, AXIN2, and CTNNB1 (β-catenin) [29]. This evidence concerns the gene PODXL and urinary bladder cancer.